These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9861303)
21. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart. Sakai S; Miyauchi T; Sakurai T; Kasuya Y; Ihara M; Yamaguchi I; Goto K; Sugishita Y Circulation; 1996 Mar; 93(6):1214-22. PubMed ID: 8653844 [TBL] [Abstract][Full Text] [Related]
22. Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction. Dupuis J; Rouleau JL; Cernacek P Circulation; 1998 Oct; 98(16):1684-7. PubMed ID: 9778335 [TBL] [Abstract][Full Text] [Related]
23. Myocardial contractile responsiveness to endothelin-1 in the post-infarction rat model of heart failure: effects of chronic quinapril. Qi XL; Sia YT; Stewart DJ; Wei G; Nguyen QT; Cernacek P; Picard P; Sirois M; Rouleau JL J Mol Cell Cardiol; 2001 Nov; 33(11):2023-35. PubMed ID: 11708846 [TBL] [Abstract][Full Text] [Related]
24. Importance of local production of endothelin-1 and of the ET(B)Receptor in the regulation of pulmonary vascular tone. Dupuis J; Jasmin JF; Prié S; Cernacek P Pulm Pharmacol Ther; 2000; 13(3):135-40. PubMed ID: 10873551 [TBL] [Abstract][Full Text] [Related]
25. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure. Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099 [TBL] [Abstract][Full Text] [Related]
26. Chronic effects of a novel, orally active endothelin receptor antagonist, T-0201, in dogs with congestive heart failure. Ohnishi M; Wada A; Tsutamoto T; Fukai D; Sawaki M; Maeda Y; Kinoshita M J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S236-8. PubMed ID: 9595447 [TBL] [Abstract][Full Text] [Related]
27. Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart. Kobayashi T; Miyauchi T; Sakai S; Kobayashi M; Yamaguchi I; Goto K; Sugishita Y Am J Physiol; 1999 Apr; 276(4):H1197-206. PubMed ID: 10199843 [TBL] [Abstract][Full Text] [Related]
28. Endothelin-1 promotes vascular structural remodeling during the progression of heart failure prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor. Wang X; Ohnishi M; Wada A; Tsutamoto T; Sawaki M; Fujii M; Matsumoto T; Yamamoto T; Kurokawa K; Yamada H; Kinoshita M Life Sci; 2001 Oct; 69(21):2477-88. PubMed ID: 11693256 [TBL] [Abstract][Full Text] [Related]
29. The effect of endothelin-1 on alveolar fluid clearance and pulmonary edema formation in the rat. Berger MM; Rozendal CS; Schieber C; Dehler M; Zügel S; Bardenheuer HJ; Bärtsch P; Mairbäurl H Anesth Analg; 2009 Jan; 108(1):225-31. PubMed ID: 19095854 [TBL] [Abstract][Full Text] [Related]
33. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist. Zhang Y; Oliver JR; Horowitz JD Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310 [TBL] [Abstract][Full Text] [Related]
34. Contribution of the endothelin system to the renal hypoperfusion associated with experimental congestive heart failure. Friedrich EB; Muders F; Luchner A; Dietl O; Riegger GA; Elsner D J Cardiovasc Pharmacol; 1999 Oct; 34(4):612-7. PubMed ID: 10511139 [TBL] [Abstract][Full Text] [Related]
35. Pulmonary hemodynamics and endothelin levels in pacing-induced heart failure: during rest and exercise. Kribbs SB; Clair MJ; Krombach RS; Hendrick JW; Thomas PB; Keever AT; Houch WV; Mukherjee R; Spinale FG J Card Fail; 1997 Dec; 3(4):263-70. PubMed ID: 9547440 [TBL] [Abstract][Full Text] [Related]
36. Downregulation of the endothelin system of lung myofibroblasts in congestive heart failure. Préfontaine A; Calderone A; Dupuis J J Cardiovasc Pharmacol; 2009 Aug; 54(2):147-53. PubMed ID: 19528809 [TBL] [Abstract][Full Text] [Related]
37. Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention. Schirger JA; Chen HH; Jougasaki M; Lisy O; Boerrigter G; Cataliotti A; Burnett JC Circulation; 2004 Jan; 109(2):249-54. PubMed ID: 14691038 [TBL] [Abstract][Full Text] [Related]
38. The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure. Saad D; Mukherjee R; Thomas PB; Iannini JP; Basler CG; Hebbar L; O SJ; Moreland S; Webb ML; Powell JR; Spinale FG J Am Coll Cardiol; 1998 Nov; 32(6):1779-86. PubMed ID: 9822109 [TBL] [Abstract][Full Text] [Related]
39. Endothelin-1 in heart and pulmonary tissue in experimental heart failure. Sirviö ML; Helin K; Stewen P; Tikkanen I; Fyhrquist F Blood Press; 1997 Jul; 6(4):250-5. PubMed ID: 9296313 [TBL] [Abstract][Full Text] [Related]
40. Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017. Na T; Dai DZ; Tang XY; Dai Y Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):39-49. PubMed ID: 17287947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]